Image guided therapy – Do we get the picture?

References

• Combs SE, Debus J. Treatment with heavy charged particles: Systematic review of clinical data and current clinical (comparative) trials. Acta Oncol 2013;52:1272–86.
   PubMed Web of Science ®Google Scholar
• Henderson RH, Hoppe BS, Marcus RB, Jr., Mendenhall WM, Nichols RC, Li Z, et al. Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials. Acta Oncol 2013;52:463–9.
   PubMed Web of Science ®Google Scholar
• Kil WJ, Nichols RC, Jr., Hoppe BS, Morris CG, Marcus RB, Jr., Mendenhall W, et al. Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression. Acta Oncol 2013;52:492–7.
   PubMed Web of Science ®Google Scholar
• Liao Z, Lin SH, Cox JD. Status of particle therapy for lung cancer. Acta Oncol 2011;50:745–56.
   PubMed Web of Science ®Google Scholar
• Mendenhall NP, Malyapa RS, Su Z, Yeung D, Mendenhall WM, Li Z. Proton therapy for head and neck cancer: Rationale, potential indications, practical considerations, and current clinical evidence. Acta Oncol 2011;50:763–71.
   PubMed Web of Science ®Google Scholar
• Schippers JM, Lomax AJ. Emerging technologies in proton therapy. Acta Oncol 2011;50:838–50.
   PubMed Web of Science ®Google Scholar
• Winther M, Alsner J, Tramm T, Nordsmark M. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer. Acta Oncol 2013;52:1327–35.
   PubMed Web of Science ®Google Scholar
• Pasini FS, Maistro S, Snitcovsky I, Barbeta LP, Rotea Mangone FR, Lehn CN, et al. Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma. Acta Oncol 2012;51:77–85.
   PubMed Web of Science ®Google Scholar
• Halle C, Andersen E, Lando M, Aarnes EK, Hasvold G, Holden M, et al. Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. Cancer Res 2012;72:5285–95.
   PubMed Web of Science ®Google Scholar
• Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer 2012;48:441–6.
   PubMed Web of Science ®Google Scholar
• Koolen BB, van der Leij F, Vogel WV, Rutgers EJ, Vrancken Peeters MJ, Elkhuizen PH, et al. Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer. Acta Oncol 2013; 53:50–57.
   PubMed Web of Science ®Google Scholar
• Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, et al. Multimodal functional imaging for early response assessment in GIST patients treated with imatinib. Acta Oncol 2013; 53:143–158.
   PubMed Web of Science ®Google Scholar
• Hompland T, Ellingsen C, Galappathi K, Rofstad EK. Connective tissue of cervical carcinoma xenografts: Associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI. Acta Oncol 2013; 53:6–15.
   PubMed Web of Science ®Google Scholar
• Borren A, Groenendaal G, Moman MR, Boeken Kruger AE, van Diest PJ, van Vulpen M, et al. Accurate prostate tumour detection with multiparametric magnetic resonance imaging: Dependence on histological properties. Acta Oncol 2013; 53:88–95.
   PubMed Web of Science ®Google Scholar
• Zilli T, Jorcano S, Peguret N, Caparrotti F, Hidalgo A, Khan HG, et al. Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis. Acta Oncol 2013;53:96–102.
   PubMed Web of Science ®Google Scholar
• Nielsen TB, Hansen O, Schytte T, Brink C. Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose. Acta Oncol 2013;53:119–125.
   PubMed Web of Science ®Google Scholar
• Bassler N, Jakel O, Sondergaard CS, Petersen JB. Dose- and LET-painting with particle therapy. Acta Oncol 2010;49:1170–6.
   PubMed Web of Science ®Google Scholar
• Giantsoudi D, Grassberger C, Craft D, Niemierko A, Trofimov A, Paganetti H. Linear energy transfer-guided optimization in intensity modulated proton therapy: Feasibility study and clinical potential. Int J Radiat Oncol Biol Phys 2013;87:216–22.
   PubMed Web of Science ®Google Scholar
• Grassberger C, Trofimov A, Lomax A, Paganetti H. Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning. Int J Radiat Oncol Biol Phys 2011;80:1559–66.
   PubMed Web of Science ®Google Scholar
• Zeng C, Giantsoudi D, Grassberger C, Goldberg S, Niemierko A, Paganetti H, et al. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions. Med Phys 2013;40:051708.
   Web of Science ®Google Scholar
• Bassler N, Toftegaard J, Luhr A, Sorensen BS, Scifoni E, Kramer M, et al. LET-painting increases tumour control probability in hypoxic tumours. Acta Oncol 2013; 53:25–38.
   PubMed Web of Science ®Google Scholar
• Sjostedt S, Bezak E, Marcu L. Experimental investigation of the cell survival in dose cold spot. Acta Oncol 2013; 53:16–24.
   PubMed Web of Science ®Google Scholar